# To Evaluate the Performance and Safety of RisoR Crest Everolimus Eluting Coronary Stent System

Study · id `cardio:ct-nct07098195` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07098195](<https://clinicaltrials.gov/study/NCT07098195>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07098195

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 2000 participants.

## Technical summary

Registry record NCT07098195. Allocation not applicable; no masking; primary purpose treatment. Start 2025-08-18 (anticipated); primary completion 2027-08-17 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 2000 participants (planned count; ClinicalTrials.gov record NCT07098195, source copy `cardio:ctgov-nct07098195-2025-08-01`, retrieved 2026-10-26)
- Planned start: 2025-08-18 (anticipated) (ClinicalTrials.gov record NCT07098195, source copy `cardio:ctgov-nct07098195-2025-08-01`, retrieved 2026-10-26)
- Primary completion: 2027-08-17 (anticipated) (ClinicalTrials.gov record NCT07098195, source copy `cardio:ctgov-nct07098195-2025-08-01`, retrieved 2026-10-26)
- Completion: 2028-01-17 (anticipated) (ClinicalTrials.gov record NCT07098195, source copy `cardio:ctgov-nct07098195-2025-08-01`, retrieved 2026-10-26)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07098195-2025-08-01`, retrieved 2026-10-26)

## The registry's words

- Brief title: To Evaluate the Performance and Safety of RisoR Crest Everolimus Eluting Coronary Stent System
- Acronym: PACIFIER
- Condition: Coronary Artery Disease
- Condition: Coronary Artery Stenosis
- Condition: Percutaneous Coronary Intervention
- Condition: de Novo Lesions in Native Coronary Arteries
- Intervention (Device): Coronary Stent
- Lead sponsor: Poly Medicure Limited
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)

## Provenance

Content hash: 48641a86563a5032ec6dadcbe6ad4d2252e7a7c8032e59fcaf40ef8cf4898631
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
